OUR MISSION

We aspire to develop a completely in situ platform drug technology optimized for solid tumor cancers that achieves CAR-T like efficacy demonstrated in liquid tumors

EXECUTIVE LEADERSHIP

CHARLES LINK, M.D.

EXECUTIVE CHAIRMAN

EAMONN HOBBS

PRESIDENT & CHIEF EXECUTIVE OFFICER

JEFFREY KRAWS

CHIEF FINANCIAL OFFICER

AGUSTIN GAGO

CHIEF BUSINESS OFFICER

MARIO MAUTINO, PH.D.

CHIEF SCIENTIFIC OFFICER

WAYNE FROST, PHARM.D., J.D.

CHIEF REGULATORY OFFICER

BOARD OF DIRECTORS

CHARLES LINK, M.D.

EXECUTIVE CHAIRMAN

EAMONN HOBBS

PRESIDENT & CHIEF EXECUTIVE OFFICER

DOUGLAS WATSON

LEAD INDEPENDENT DIRECTOR

JOSEPH MAROON, M.D.

INDEPENDENT DIRECTOR

JEFFREY CLELAND, PH.D.

INDEPENDENT DIRECTOR

NORMAN SCHWARTZ

INDEPENDENT DIRECTOR

SCIENTIFIC ADVISORY BOARD

JON CONDRA, PH.D.

  • Merck Research Laboratories (retired)
  • Former Associate Professor, Temple University School of Pharmacy

ALAN EPSTEIN, PH.D.

  • University of Southern California
  • Professor, Keck School of Medicine

RICHARD HARRIS, M.D.

  • CEO of UroPartners
  • President of Large Urology Group Practice Association (LUGPA) BOD

JOHN MORRIS, M.D.

  • Director, Experimental Therapeutics at Cincinnati College of Medicine
  • Co-Director, Comprehensive Lung Cancer Center
  • Associate Director, UCCI Translational Research

GEORGE C. PRENDERGAST, PH.D.

  • President and CEO of the Lankenau Institute for Medical Research (LIMR)
  • Former Editor-in-Chief of Cancer Research

THOMAS RAFFIN, M.D.

  • Stanford University School of Medicine Colleen and Robert Haas Professor Emeritus of Medicine and Biomedical Ethics
  • Former Chief of Pulmonary and Critical Care Medicine

DAVID STARK, M.D.

  • Former Chairman of the Department of Radiology, State University of New York, Downstate Medical Center

KENNETH THOMSON, M.D.

  • Former Adjunct Professor and Director of Radiology, Alfred Hospital
  • Former Deputy Director of Radiology and Head of Interventional Radiology, The Royal Melbourne Hospital

DAVID VAUGHAN, M.D.

  • Former Chairman of Department of Urology at Florida Hospital & Winter Park Hospital
  • Former Partner of Orlando Urology Associates

SUMING WANG, M.D., PH.D.

  • Founded Shanghai Mingda Biotech, an immune therapy company in 2014
  • Former CEO of Shanghai East International Medical Center
  • Vice President of NewLink Genetics from 1999-2008

JASON WILLIAMS, M.D.

  • Chief of Interventional Oncology and Immunotherapy, Williams Cancer Institute
  • Adjunct Associate Professor, Case Western Reserve University
  • Author “The Immunotherapy Revolution”

YOUSEF ZAKHARIA, M.D.

  • Clinical Associate Professor of Medicine, University of Iowa
  • Director Phase I Program, Co-Leader Genitourinary Oncology Program, University of Iowa

Syncromune™ © 2023   ·   Terms of Use   |   Privacy   |   Cookies